Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (17039)	12/17/1998 10:32:00 PM
From: AlienTech	Respond to of 23519

Anyone intrested in this? >> Hi, I'm a reporter with the Wall Street Journal Interactive Edition. I'm looking into a piece on shorting OTC BB stocks, and came across your post "Market Maker Speaks Out." I'm interested in talking to you, you seem to be very knowledgeable in this complex area. Please give me a call (collect is OK) at your earliest convenience, 212-416-XXXX. Thanks, XXXXX Reporter Wall STreet Journal Interactive Edition

To: VLAD who wrote (17039)	12/17/1998 10:37:00 PM
From: Frostman	Read Replies (1) \| Respond to of 23519

Vlad, re the announcement. Vivus timing was good, but we have learned nothing concrete regarding marketing plans for 1999 in the United States. The fact that Vivus is gaining more leverage for a partnership deal at some undisclosed time in the future does not address how to move product off the shelf today. Are we to assume that Viagra safety issues are the lead-sales resource for our little company here in America? Another lost opportunity to increase credibility. I give the effort a "c-" There is, however, no question who wrote this one. Frostman